Page last updated: 2024-11-05

thiotepa and Asthma

thiotepa has been researched along with Asthma in 3 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nemchinov, NN3

Other Studies

3 other studies available for thiotepa and Asthma

ArticleYear
[Treatment of infectious-allergic bronchial asthma with thiophosphamide].
    Terapevticheskii arkhiv, 1978, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Asthma; Humans; Middle Aged; Thiotepa

1978
[Thiophosphamide in the complex treatment of infectious allergic bronchial asthma].
    Sovetskaia meditsina, 1976, Issue:10

    Topics: Asthma; Drug Therapy, Combination; Female; Humans; Male; Thiotepa

1976
[Use of thiophosphamide in the treatment of patients with bronchial asthma].
    Vrachebnoe delo, 1973, Volume: 9

    Topics: Adolescent; Adult; Aged; Asthma; Female; Humans; Male; Middle Aged; Thiotepa

1973